Xploit Semantic Support for predictive modeling in Systems Medicine

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00026643

Enrollment

400

Registered

2021-09-15

Start date

2017-09-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C92.0 C91.0 T86.0 B25.9

Interventions

Group 1: Non-interventional. Regular follow up according to guidelines. Data collection. The aim of the study is the prospective validation of transplant risk models that have been developed using dif

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: First allogeneic HCT

Exclusion criteria

Exclusion criteria: Second or further allogeneic HCT, Hemoglobinopathies.

Design outcomes

Primary

Measure	Time frame
Overall survival	—

Secondary

Measure	Time frame
Cytomegalovirus reactivation within first 100 days from HCT	—

Countries

Germany

Contacts

Public ContactAmin Turki

Universitätsklinikum Essen

amin.turki@uk-essen.de+49-201-723-0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026